Related Experiment Video
Updated: Feb 14, 2026

Electrophysiological Measurements and Analysis of Nociception in Human Infants
Published on: December 20, 2011
Group B Streptococcal Cellulitis and Necrotizing Fasciitis in Infants: A Systematic Review
Monika Wojtera1, Horace Cheng2,3, Kyle Fiorini1,3
1From the Schulich School of Medicine and Dentistry.
Insights
Group B Streptococcus (GBS) head and neck infections in infants, including cellulitis and necrotizing fasciitis, lack a clear treatment consensus. Conservative antibiotic treatment can be effective, but severe cases may require surgical debridement.
Area of Science:
- Neonatal infections
- Pediatric infectious diseases
- Microbiology
Background:
- Group B Streptococcus (GBS) can cause severe skin and soft tissue infections in infants.
- There is a lack of established guidelines for managing infantile GBS head and neck cellulitis and necrotizing fasciitis.
Observation:
- A case of GBS facial necrotizing fasciitis in a 33-day-old infant was successfully managed with antibiotics alone.
- A literature review identified 40 infants with GBS head and neck cellulitis, predominantly late-onset, male, and premature.
- Twelve cases of GBS necrotizing fasciitis were identified, often polymicrobial, with 75% requiring debridement.
Findings:
- Penicillin is the primary antibiotic for GBS head and neck cellulitis (97% of cases).
- Necrotizing fasciitis cases frequently involved polymicrobial infections and broad-spectrum antibiotics.
- Head and neck necrotizing fasciitis had an 80% rate of requiring surgical debridement.
Implications:
- Early recognition and prompt antibiotic therapy are crucial for infantile GBS skin and soft tissue infections.
- Surgical debridement should be considered for severe necrotizing fasciitis cases.
- Further research is needed to establish optimal management strategies for these rare but serious infections.
Background:
There is no consensus regarding approaches to infantile group B streptococcal (GBS) head and neck cellulitis and necrotizing fasciitis. We present a case of GBS necrotizing cellulitis and summarize the literature regarding the presentation and management of infantile head and neck GBS cellulitis and necrotizing fasciitis.
Methods:
The literature was searched using PubMed, Web of Science, EMBASE and Medline (inception to April 2017) by 2 independent review authors. Inclusion criteria encompassed case reports or case series of infants less than 12 months of age with GBS cellulitis of the head and neck or with GBS necrotizing fasciitis without restriction to the head and neck. Data were extracted using tables developed a priori by 2 independent review authors, and discrepancies were resolved by consensus.
Results:
An infant presenting at 33 days of age with GBS facial necrotizing fasciitis was successfully treated conservatively with antibiotics. Our literature search identified 40 infants with GBS head and neck cellulitis. Late-onset (98%), male gender (65%) and prematurity (58%) predominated. Penicillin is the main therapy used (97%). The 12 identified cases of necrotizing fasciitis were associated with polymicrobial etiology (36%) and broad-spectrum antibiotic use. Seventy-five percent required debridement, including 4 of 5 (80%) cases involving the head and neck.
Conclusions:
Skin and soft tissue involvement is an uncommon manifestation of late-onset GBS infection which requires antibiotic therapy and possibly surgical debridement cases with necrotizing fasciitis.
Related Concept Videos
Review and Preview
Percentiles are a type of fractile that partition data into...
Review and Preview
Random and Systematic Errors
Systematic Sampling Method
Systematic sampling is one of the simplest methods...
Propagation of Uncertainty from Systematic Error
Drug Dosing: Infants and Children

